story of the week
Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE)
J. Clin. Oncol 2020 Oct 27;[EPub Ahead of Print], RR McKay, BA McGregor, W Xie, DA Braun, X Wei, CE Kyriakopoulos, Y Zakharia, BL Maughan, TL Rose, WM Stadler, DF McDermott, LC Harshman, TK ChoueiriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.